Cargando…

Concerning data inconsistencies in Burkitt lymphoma genome study

Detalles Bibliográficos
Autores principales:	Rushton, Christopher K., Dreval, Kostiantyn, Morin, Ryan D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Letter to Blood
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644070/ https://www.ncbi.nlm.nih.gov/pubmed/36302254 http://dx.doi.org/10.1182/blood.2022016505

Ejemplares similares

Minimal information for reporting a genomics experiment
por: Dreval, Kostiantyn, et al.
Publicado: (2022)

Humoral and cellular responses after COVID-19 vaccination in anti-CD20-treated lymphoma patients
por: Liebers, Nora, et al.
Publicado: (2022)

Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies
por: Ghione, Paola, et al.
Publicado: (2021)

CD19 target evasion as a mechanism of relapse in large B-cell lymphoma treated with axicabtagene ciloleucel
por: Plaks, Vicki, et al.
Publicado: (2021)

Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell–depleted lymphoma after CART therapy
por: Atanackovic, Djordje, et al.
Publicado: (2022)

Prostaglandin-like substances in Burkitt lymphoma tissue.
por: Ajayi, O. O., et al.
Publicado: (1977)

Shared and distinct genetic features in human and canine B-cell lymphomas
por: Coyle, Krysta Mila, et al.
Publicado: (2022)

Determinants of blood donation willingness in the European Union: a cross‐country perspective on perceived transfusion safety, concerns, and incentives
por: Huis in ‘t Veld, Elisabeth M.J., et al.
Publicado: (2019)

Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study
por: Tremblay, Douglas, et al.
Publicado: (2020)

Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19
por: Miller, Peter G., et al.
Publicado: (2022)

Antiplatelet drugs block platelet activation by VITT patient serum
por: Smith, Christopher W., et al.
Publicado: (2021)

House calls for stem cell transplant patients during the COVID-19 pandemic
por: Sung, Anthony D., et al.
Publicado: (2020)

Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts
por: Zeidan, Amer M., et al.
Publicado: (2022)

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
por: Treon, Steven P., et al.
Publicado: (2020)

Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia
por: Weeks, Lachelle D., et al.
Publicado: (2022)

Use of convalescent plasma in hospitalized patients with COVID-19: case series
por: Hegerova, Livia, et al.
Publicado: (2020)

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?
por: Frigault, Matthew J., et al.
Publicado: (2020)

Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose
por: Terpos, Evangelos, et al.
Publicado: (2021)

COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
por: Roeker, Lindsey E., et al.
Publicado: (2021)

Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphoma
por: Reutter, Katrin, et al.
Publicado: (2020)

Vacuolization of hematopoietic precursors: an enigma with multiple etiologies
por: Gurnari, Carmelo, et al.
Publicado: (2021)

Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis
por: Kolijn, P. Martijn, et al.
Publicado: (2023)

Prebiotic galactooligosaccharides interact with mouse gut microbiota to attenuate acute graft-versus-host disease
por: Holmes, Zachary C., et al.
Publicado: (2022)

Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients
por: Maillard, Alexis, et al.
Publicado: (2022)

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia
por: Chitadze, Guranda, et al.
Publicado: (2023)

Simplified detection of Epstein-Barr virus for diagnosis of endemic Burkitt lymphoma
por: Gardner, Andrea, et al.
Publicado: (2022)

Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance
por: Ho, Matthew, et al.
Publicado: (2022)

Clonal hematopoiesis is not significantly associated with COVID-19 disease severity
por: Zhou, Yifan, et al.
Publicado: (2022)

Prediction paradigm involving time series applied to total blood issues data from England
por: Nandi, Anita K., et al.
Publicado: (2020)

High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients
por: Oliva-Ariza, Guillermo, et al.
Publicado: (2023)

Neutrophil-specific depletion of gasdermin D does not protect against murine sepsis
por: Liu, Fei, et al.
Publicado: (2023)

Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies
por: Davis, James A., et al.
Publicado: (2023)

Prospective validation of the prognostic relevance of CD34(+)CD38(–) AML stem cell frequency in the HOVON-SAKK132 trial
por: Ngai, Lok Lam, et al.
Publicado: (2023)

F9 mutations causing deletions beyond the serine protease domain confer higher risk for inhibitor development in hemophilia B
por: Liu, Guoqing, et al.
Publicado: (2023)

Tumor microenvironment contribution to checkpoint blockade therapy: lessons learned from Hodgkin lymphoma
por: Carbone, Antonino, et al.
Publicado: (2023)

No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation
por: Cappy, Pierre, et al.
Publicado: (2020)

Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report
por: Cuneo, Antonio, et al.
Publicado: (2020)

Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion
por: Xia, Xinyi, et al.
Publicado: (2020)

Red cell–bound antibodies and transfusion requirements in hospitalized patients with COVID-19
por: Berzuini, Alessandra, et al.
Publicado: (2020)

Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic
por: Nickel, Robert Sheppard, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mebjmpnpao3uvp63iq6ggouif8